RxDoctor Payments DataLook up a doctor →

Karla Houston-Gray, MD

Internal Medicine · Kansas City, MONPI 1003801085

Payments from drug & device makers

$24,375in general payments, 2019–2025

Across 1,364 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$4K
  • Novo Nordisk$2K
  • AbbVie$2K
  • Boehringer Ingelheim$1K
  • Lilly USA, LLC$1K
  • GSK$1K
  • plus $12K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)164$3,810
Novo Nordisk124$2,430
AbbVie145$2,319
Boehringer Ingelheim85$1,316
Lilly USA, LLC72$1,284
GSK73$1,168
Pfizer82$1,000
Regeneron Healthcare Solutions, Inc.35$974
Merck57$872
Amgen(2 entities)52$715
Sanofi26$668
Johnson & Johnson27$517
Amarin Pharma, Inc.30$474
Sunovion Pharmaceuticals Inc.32$465
Astellas Pharma US Inc28$458
United Therapeutics Corporation18$434
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC25$374
Sumitomo Pharma America, Inc.18$291
Jazz Pharmaceuticals Inc.9$263
Harmony Biosciences LLC8$232
Kowa Pharmaceuticals America, Inc.19$232
Abbott12$212
Philips North America LLC11$205
Takeda Pharmaceuticals U.S.A., Inc.12$193
Gilead11$189
Sanofi-aventis U.S. LLC14$173
Grifols USA, LLC8$170
Insulet Corporation4$157
Eisai Inc.9$146
Novartis9$144
Mylan Specialty L.p.10$137
Baxter Healthcare7$124
Scilex Pharmaceuticals Inc.7$120
Teva Pharmaceuticals USA, Inc.7$114
Actelion Pharmaceuticals US, Inc.6$105
Incyte Corporation1$99
Mallinckrodt Hospital Products Inc.4$97
E.r. Squibb & Sons, L.L.C.6$90
Ironwood Pharmaceuticals, Inc6$88
Ardelyx, Inc.4$84
Viatris Specialty LLC4$74
Alnylam Pharmaceuticals Inc.4$71
Genentech USA, Inc.4$69
Nevro Corp.3$68
ANI Pharmaceuticals, Inc.4$67
Electromed, Inc.7$64
Exact Sciences4$63
Xeris Pharmaceuticals, Inc.3$51
Medtronic(2 entities)3$50
Vanda Pharmaceuticals Inc.2$49
Boston Scientific3$48
Dynavax Technologies Corporation3$48
Bayer3$47
Inogen, Inc.2$47
Idorsia Pharmaceuticals US Inc3$46
Verona Pharma, Inc.3$43
Biogen3$40
Cequr Corporation1$39
Aytu Biopharma, Inc.3$38
Global Blood Therapeutics, Inc.2$38

How this compares

$24,375 in reported general payments places this provider in the 95th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri →

Medicare billing

Part B allowed, 2024
$50,675
Medicare patients
145
Services billed
544

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Kansas City

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →